We turn the investment thesis into results across the deal cycle — diligence to exit. For funds, family offices, and holdcos backing businesses across Africa, we execute inside the portfolio.
We take part of our upside in the outcome, not just the invoice — success fees, sweat equity, or co-investment. We build and own our own ventures, so the alignment is real.
AI-native execution turns quarters into weeks. Committed time is where compounding starts.
We close the gap between analysis and execution. The deliverable is a working system and a number that moved.
The thesis is rarely the problem. The distance between it and a company that has actually changed is where returns are won or lost.
Diligence models the financials, then stops at the door of the operation — where the return actually lives.
The 100-day plan waits on tools and reporting that don't exist yet. Every quarter of lag is value leaking out.
Three modular stages. Engage the whole arc, or the single stage where the value is leaking — each one stands on its own.
We turn the thesis into a priced, testable operational view before the deal closes.
We step in and build the systems the plan depends on — one point of truth the board, the operator, and the fund all read from.
We make the value legible to a buyer — clean data, evidenced value drivers, no surprises in diligence.
A private hospital group carrying value it could not see. We built one point of truth across the operation, surfaced revenue it was quietly losing, and stood up the scorecards the board now steers with.
Details are anonymised. The full case is shared under a confidential introduction.
If value’s leaking between your thesis and your portfolio, let’s find it.
Book a Conversation